The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda
- PMID: 31721082
- PMCID: PMC8012007
- DOI: 10.1007/s13365-019-00806-2
The Veterans Aging Cohort Study Index is not associated with HIV-associated neurocognitive disorders in Uganda
Abstract
The Veterans Aging Cohort Study (VACS) Index has been associated with HIV-associated neurocognitive disorder (HAND) in some populations but has not been studied in sub-Saharan Africa. We investigated whether the VACS Index is associated with HAND in a rural population in Rakai, Uganda. HIV-infected (HIV+) adults on antiretroviral therapy underwent a neurocognitive battery for determination of HAND stage using Frascati criteria. VACS component scores were recorded for all participants. Out of 156 study participants, HAND stages were 49% normal cognition, 15% asymptomatic neurocognitive impairment, 31% minor neurocognitive disorder, and 7% HIV-associated dementia. There was no significant association between VACS Index and any HAND stage. In this first study of the VACS Index in sub-Saharan Africa, we found no association between VACS Index score and HAND.
Keywords: Global health; HIV; HIV-associated neurocognitive disorder; Uganda; Veterans aging cohort study index.
Conflict of interest statement
Conflicts of Interest
Dr. Violet Awori reports no conflicts of interest.
Dr. Gertrude Nakigozi reports no conflicts of interest.
Dr. Alice Kisakye reports no conflicts of interest.
Dr. James Bette reports no conflicts of interest.
Mr. Aggrey Anok reports no conflicts of interest.
Mr. Richard Mayanja reports no conflicts of interest.
Dr. Noeline Nakasujja reports no conflicts of interest.
Dr. Kevin R. Robertson reports no conflicts of interest.
Dr. Ronald H. Gray reports no conflicts of interest.
Dr. Maria J. Wawer reports no conflicts of interest.
Dr. Ned Sacktor reports no conflicts of interest.
Dr. Deanna Saylor reports no conflicts of interest.
References
-
- Hammer SM, Squires KE, Hughes MD, Grimes JM, Demeter LM, Currier JS, … Cook JC (2002). A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less. New England Journal of Medicine. 10.1056/nejm199709113371101 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
- NS065729-05S2/NS/NINDS NIH HHS/United States
- P30 MH075673/MH/NIMH NIH HHS/United States
- L30NS088658/NS/NINDS NIH HHS/United States
- P30 AI094189/AI/NIAID NIH HHS/United States
- R01 MH120693/MH/NIMH NIH HHS/United States
- R25 NS065729/NS/NINDS NIH HHS/United States
- P30AI094189-01A1/National Institute of Allergy and Infectious Diseases/International
- R25 MH080661/MH/NIMH NIH HHS/United States
- L30 NS088658/NS/NINDS NIH HHS/United States
- R01 MH099733/MH/NIMH NIH HHS/United States
- MH080661-08/MH/NIMH NIH HHS/United States
- MH075673/MH/NIMH NIH HHS/United States
- MH099733/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources